H2020Staff exchange2020–2024

ENCAP4HEALTH · Innovative sustainable ENCAPsulation systems for improving human HEALTH and well-being

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2020-01-01 → 2024-06-30
EU contribution
€607,200
Participants
12
Scheme
MSCA-RISE

Lines connect the coordinator with its partners.

Results in brief

Innovative sustainable ENCAPsulation systems for improving human HEALTH and well-being

Improving health and well-being in general and maintaining good health until an advanced age are key societal challenges and have become the most pressing issues in European health policy. An adequate supply of micronutrients, (i.e. vitamins and minerals) and pre-, probiotics is required to keep healthy and support the human microbiome.Encapsulation techniques may be used to improve protection and control the release of these so-called bioactive food constituents. Experts have emphasised for a long time that new methods and materials are required to improve the functionality, digestibility and absorption of bioactives. With an increasing awareness of zero-waste production and reduction of the environmental impact of food processing, opportunities to create a new generation of encapsulation systems have opened up. Thus, ENCAP4HEALTH aimed to create innovative, biopolymer-based microcapsules that can serve as advanced delivery systems for vital nutrients. By identifying new biopolymers and developing more efficient, sustainable encapsulation technologies, ENCAP4HEALTH has contributed to the next generation of functional food ingredients. ENCAP4HEALTH has provided a set of new alternative proteins and nutritional fibre extracted from industrial side-products of conventional food processing, making the value chain more sustainable. Proteins extracted from peas, hemp, potatoes, green leaves, nutritional fibre extracted from carrots and pectins isolated from several sources were identified as valuable new ingredients. Additionally, ENCAP4HEALTH optimised the established technologies of external gelation or electro-dripping to produce microcapsules based on the new ingredients. At this point, research focused on increasing the productivity of the process on an industrial scale. Furthermore, researchers developed innovative strategies to reduce the current production methods' energetic demand through static mixers or membrane emulsification. Finally, ENCAP4HEALTH members produced different microcapsules with tailor-made formulations and functionality (beads, coacervates, coated coacervates). ENCAP4HEALTH studied the behaviour of the microcapsules during in vitro digestion. Most microcapsules resisted the gastric phase and disintegrated in the intestinal phase, as required for delivery systems. Some specific formulations containing citrus pectin proved to be very effective in protecting against adverse conditions in the gastrointestinal tract and are specifically suitable for use in probiotics or beneficial bacteria applications. In summary, ENCAP4HEALTH has developed customised, functional delivery systems that play a critical role in improving human health. These systems protect essential nutrients, enhance their bioavailability, and support the delivery of probiotics, thereby contributing to a healthier, more nutritionally adequate diet.

Data: CORDIS, © European Union

Project objective

Improvement and maintenance of health, particularly in ageing societies, is a major challenge defined in H2020. In this context, the objective of ENCAP4HEALTH is to develop innovative concepts for biopolymer-based microcapsules resulting in a new generation of highly functional delivery systems for functional food ingredients. Experts have emphasized for a long time that new methods and materials are required to improve functionality, digestibility and absorption of these so-called bioactives. With an increasing awareness for zero-waste production and reduction of the environmental impact of food processing, opportunities to create a new generation of encapsulation systems open up. ENCAP4HEALTH will bring together more than 50 international experts with ample expertise from 12 different institutions (technical, medical and traditional universities, SMEs and multinational companies). The network aims to identify new biopolymers and to develop more efficient and sustainable processing technologies for encapsulation. The action is divided into six work packages, three of them devoted to scientific research and three to training, career development, dissemination and exploitation as well as management. Multiple training activities related to these work packages have been specifically designed to improve the skills of the consortium members and to promote their career development. Gender aspects will adequately be addressed in training and research. Exploitation of results will boost innovation and present societal and economic benefits by producing more effective functional food applying new and optimized encapsulation techniques. ENCAP4HEALTH will lead to a greater affordability of multiple health and food applications opening market opportunities in the food sector, that will spread out to agriculture, feed, pharma and even the biomedical sector.

Original text from CORDIS.

Participants

  • TECHNISCHE UNIVERSITAT BERLIN · BerlinCoordinatorGermany
  • ACADEMISCH ZIEKENHUIS GRONINGEN · GroningenNetherlands
  • ANABIO TECHNOLOGIES LTD · Dublin 2Ireland
  • CP KELCO APS · Lille SkensvedDenmark
  • ENCAPPROCESS · NantesFrance
  • INSTITUTO NACIONAL DE TECNOLOGIA INDUSTRIAL · Buenos AiresArgentina
  • LOUGHBOROUGH UNIVERSITY · LoughboroughUnited Kingdom
  • MICROPORE TECHNOLOGIES LTD · Hatton DerbyshireUnited Kingdom
  • SAPORITI SA · Buenos AiresArgentina
  • SYMRISE AG · HolzmindenGermany
  • TEAGASC - AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY · CarlowIreland
  • UNIVERSIDAD DE LA FRONTERA · TemucoChile

Links

Data: CORDIS, © European Union